Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.85% |
| 2 | Technology | 3.12% |
| 3 | Healthcare | 2.55% |
| 4 | Financials | 2.39% |
| 5 | Consumer Discretionary | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6701
CALL
Zentalis Pharmaceuticals
ZNTL
$239M
| $1.11M | ﹤0.01% |
51,200
+31,100
| +155% | +$850K |
2021 Q2
5 quarters
|
|
|
ATXS
6702
DELISTED
Astria Therapeutics
ATXS
| $1.11M | ﹤0.01% |
122,476
-97,486
| -44% | -$653K |
2020 Q4
7 quarters
|
|
6703
CALL
Enlivex Ltd
ENLV
$7.71M
| $1.11M | ﹤0.01% |
17,380
+16,200
| +1,373% | +$1.18M |
2022 Q2
1 quarter
|
|
6704
CALL
FB Financial Corp
FBK
$2.67B
| $1.11M | ﹤0.01% |
+29,000
| New | +$1.18M |
2022 Q3
0 quarters
|
|
6705
National Bank Holdings
NBHC
$1.69B
| $1.11M | ﹤0.01% |
29,941
+2,457
| +9% | +$98.7K |
2020 Q3
8 quarters
|
|
6706
PUT
The Ensign Group
ENSG
$10B
| $1.1M | ﹤0.01% |
13,900
-3,300
| -19% | -$273K |
2022 Q2
1 quarter
|
|
6707
Perion Network
PERI
$334M
| $1.1M | ﹤0.01% |
57,227
-34,569
| -38% | -$697K |
2020 Q3
8 quarters
|
|
6708
PUT
WEX
WEX
$5.76B
| $1.1M | ﹤0.01% |
8,700
-2,900
| -25% | -$456K |
2017 Q4
19 quarters
|
|
6709
CALL
Popular Inc
BPOP
$10.1B
| $1.1M | ﹤0.01% |
15,300
-25,200
| -62% | -$1.96M |
2013 Q2
37 quarters
|
|
6710
CALL
Ocugen
OCGN
$346M
| $1.1M | ﹤0.01% |
619,800
+224,000
| +57% | +$558K |
2021 Q1
6 quarters
|
|
6711
Avantor
AVTR
$10.4B
| $1.1M | ﹤0.01% |
56,238
-4,317,024
| -99% | -$116M |
2019 Q2
13 quarters
|
|
6712
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$738M
| $1.1M | ﹤0.01% |
+23,425
| New | +$1.15M |
2022 Q3
0 quarters
|
|
|
DNAD
6713
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
| $1.1M | ﹤0.01% |
111,943
-1,795
| -2% | -$17.5K |
2021 Q2
5 quarters
|
|
|
HUYA
6714
Huya Inc
HUYA
$525M
| $1.1M | ﹤0.01% |
496,214
+245,112
| +98% | +$791K |
2018 Q2
17 quarters
|
|
6715
CALL
Valmont Industries
VMI
$9.24B
| $1.1M | ﹤0.01% |
4,100
-18,100
| -82% | -$4.78M |
2013 Q2
37 quarters
|
|
|
HIBB
6716
CALL
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.1M | ﹤0.01% |
22,100
-43,900
| -67% | -$2.31M |
2017 Q3
20 quarters
|
|
|
AVDL
6717
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.1M | ﹤0.01% |
219,100
-47,200
| -18% | -$260K |
2019 Q3
12 quarters
|
|
6718
PUT
Sprout Social
SPT
$611M
| $1.1M | ﹤0.01% |
18,100
-107,400
| -86% | -$6.46M |
2021 Q1
6 quarters
|
|
6719
US Physical Therapy
USPH
$1.25B
| $1.1M | ﹤0.01% |
14,426
+9,670
| +203% | +$930K |
2017 Q1
22 quarters
|
|
|
NVTA
6720
PUT
DELISTED
Invitae Corporation
NVTA
| $1.1M | ﹤0.01% |
445,900
+89,700
| +25% | +$272K |
2017 Q2
21 quarters
|
|
|
HZON
6721
DELISTED
Horizon Acquisition Corporation II
HZON
| $1.1M | ﹤0.01% |
109,701
-210,001
| -66% | -$2.09M |
2020 Q4
7 quarters
|
|
6722
CALL
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $1.09M | ﹤0.01% |
+8,300
| New | +$1.16M |
2022 Q3
0 quarters
|
|
6723
Oracle
ORCL
$431B
| $1.09M | ﹤0.01% |
17,927
-337,919
| -95% | -$24.7M |
2013 Q2
37 quarters
|
|
6724
Precigen
PGEN
$3.06B
| $1.09M | ﹤0.01% |
516,254
-297,410
| -37% | -$627K |
2019 Q3
12 quarters
|
|
|
THRD
6725
DELISTED
Third Harmonic Bio
THRD
| $1.09M | ﹤0.01% |
+57,687
| New | +$1.04M |
2022 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors's Q3 2022 filing shows 1,622 new, 5,458 increased, 5,221 reduced and 1,857 closed positions. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M. The largest sale was Meta Platforms (Facebook), an estimated $349M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,857 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.